ArticleHealth and quality of life outcomes2006

Feedback on the FDA's February 2006 draft guidance on Patient Reported Outcome (PRO) measures from a developer of PRO measures.

Clare BradleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.